PALATIN TECHNOLOGIES, INC. Cost of Goods and Services Sold
PALATIN TECHNOLOGIES, INC. (PTN) reported Cost of Goods and Services Sold of $46.91 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-16.
Discontinued › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2022-05-16
- PALATIN TECHNOLOGIES, INC. cost of goods and services sold for the quarter ending 2022-03-31 was $46.91K, a 15.39% decline year-over-year.
- PALATIN TECHNOLOGIES, INC. cost of goods and services sold for the quarter ending 2021-12-31 was $29.17K, a 0.78% decline year-over-year.
- PALATIN TECHNOLOGIES, INC. cost of goods and services sold for the quarter ending 2021-03-31 was $55.44K.
- PALATIN TECHNOLOGIES, INC. cost of goods and services sold for the quarter ending 2020-12-31 was $29.40K.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month |
|---|---|---|---|
| 2022-03-31 | $46.91K 10-Q · filed 2022-05-16 | $76.08K derived: sum of 2 quarters · filed 2022-05-16 | $130.01K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $29.17K 10-Q · filed 2022-02-14 | $83.10K 10-Q · filed 2022-02-14 | |
| 2021-03-31 | $55.44K 10-Q · filed 2022-05-16 | $84.84K derived: sum of 2 quarters · filed 2022-05-16 | $110.04K 10-Q · filed 2022-05-16 |
| 2020-12-31 | $29.40K 10-Q · filed 2022-02-14 | $54.60K 10-Q · filed 2022-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |